Evaxion Biotech AS (EVAX) Financials

$3.12

$0.04 (1.30%)

As on 04-Sep-2026 16:00EDT

Market cap

$28 Mln

Revenue (TTM)

$8 Mln

P/E Ratio

--

P/B Ratio

2.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	7.51	7.53	3.34	0.07	--	--
Cost of Revenue	--	--	--	0.00	0.57	0.34
Gross Profit	-0.04	7.53	3.34	0.07	-0.57	-0.34
Operating Expenses	16.18	16.76	18.08	22.27	25.26	25.83
Operating Profit (EBIT)	-8.69	-9.23	-14.73	-22.20	-25.26	-25.83
Other Income	--	--	--	--	--	--
Profit before Tax	-9.59	-8.62	-11.36	-22.92	-23.94	-24.71
Provision for Tax	-0.94	-0.91	-0.79	-0.79	-0.77	-0.18
Profit after Tax (Net Income)	-8.65	-7.71	-10.57	-22.13	-23.17	-24.53
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-24.53

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	9.53	17.04	-1.65	-4.73	8.30	32.44
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	6.72	7.11	9.77	10.53	9.96	3.40
Current Liabilities	3.13	4.26	4.37	7.08	3.76	4.32
Total Liabilities	22.51	28.41	12.49	12.89	22.03	40.16

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	3.52	3.51	3.72	4.54	5.04	5.46
Current Assets	15.86	24.90	8.77	8.35	16.99	34.71
Total Assets	22.51	28.41	12.49	12.89	22.03	40.16
Total Debt*	7.10	7.50	10.10	10.87	10.26	3.69
Net Current Assets	12.73	20.64	4.40	1.27	13.22	30.38

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-6.65	-12.94	-17.69	-25.77	-21.93
Cash Flow from Investing Activities	--	-0.01	0.00	-0.09	-0.27	-1.33
Cash from Financing Activities	--	22.48	13.13	10.69	7.85	49.81
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	--	-6.11	-1.20	-0.15	-32.37	-0.96
Cash EPS ($)	--	--	-1.11	-0.14	-31.47	-0.94
Adjusted Book Value ($)	--	--	2.66	--	--	0.34
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	-1.04	-0.18	-25.89	-1.07
Free Cash Flow per Share ($)	--	--	-1.04	-0.18	-26.01	-1.08

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	--	-46.72	-144.85	-179.16	-84.74
ROE (%)	--	-65.13	-100.18	331.20	-1,238.11	-113.74
ROA (%)	--	-34.42	-37.69	-83.29	-126.74	-74.51
EBIT Margin (%)	--	-77.07	-102.80	-310.80	-30,161.64	--
Net Margin (%)	--	-115.15	-102.38	-316.00	-30,308.22	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	127.84	1.25	44.81	--	--
EBIT Growth (%)	--	20.16	25.54	52.80	4.86	5.74
Net Profit Growth (%)	--	27.74	27.07	52.24	4.51	5.56
EPS Growth (%)	--	15.76	-6.98	1.00	-32.65	0.98
Book Value Growth (%)	--	305.72	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	--	-3.97	-5.61	-0.02	-1.84
Price / Book Value	--	2.71	1.79	-35.89	-0.10	5.15
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	-0.59	-2.08	-6.57	-0.27	-1.76
Close Price ($)	--	3.10	4.77	4.23	34.30	88.75
High Price ($)	--	12.15	12.15	370.00	107.50	233.63
Low Price ($)	--	2.28	1.20	4.15	23.51	75.51
Market Cap ($ Cr)	--	28.15	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.54	0.44	-6.11	-2.30	1.24
Short term debt to equity ratio	0.03	0.06	0.03	-0.29	-0.10	0.05
Current Ratio	--	5.06	5.85	2.01	1.18	4.51
Quick Ratio	--	5.06	--	--	--	5.18
Interest Coverage	--	-2.22	-8.83	-10.80	-24.55	-15.35

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	24.73	13.96	55.56	1,472.60	--
Asset Turnover	--	0.30	0.37	0.26	0.00	--
Receivable days	--	--	70.57	160.18	5,959.08	--
Inventory Days	--	--	--	--	-8,133,543.54	-1,404.90
Payable days	--	--	--	--	7,784,390.63	1,576.86
Cash Conversion Cycle	--	--	--	--	-15,911,975.08	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.